Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableStudy completedNCT02244450
What this trial is testing

Generalized Neonatal Screening of Severe Combined Immunodeficiencies

Who this might be right for
Severe Combined Immunodeficiency, Atypical
Nantes University Hospital 190,539
Not applicableStudy completedNCT00491556
What this trial is testing

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 102
Not applicableStudy completedNCT00051831
What this trial is testing

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Looking for participantsNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Post-approval studies (Phase 4)Study completedNCT00735072
What this trial is testing

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Who this might be right for
HIV Infection
University of California, San Francisco 45
Early research (Phase 1)Study completedNCT00089531
What this trial is testing

Candidate HIV Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00007332
What this trial is testing

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 330
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Early research (Phase 1)Study completedNCT00000704
What this trial is testing

Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Testing effectiveness (Phase 2)Study completedNCT01252641
What this trial is testing

Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects

Who this might be right for
HIVHIV Infection
Sangamo Therapeutics 21
Not applicableStudy completedNCT03618862
What this trial is testing

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

Who this might be right for
Hiv
Hospices Civils de Lyon 38
Testing effectiveness (Phase 2)Looking for participantsNCT03579875
What this trial is testing

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Who this might be right for
Fanconi AnemiaSevere Aplastic AnemiaMyelodysplastic Syndromes+5 more
Masonic Cancer Center, University of Minnesota 48
Not applicableStudy completedNCT00006301
What this trial is testing

Immune Response to Hepatitis C Virus

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Not applicableStudy completedNCT01413230
What this trial is testing

Vitamin D Supplementation in Systemic Lupus Erythematosus

Who this might be right for
Vitamin D Deficiency
Assistance Publique - Hôpitaux de Paris 20
Not applicableNo Longer AvailableNCT03010332
What this trial is testing

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

Who this might be right for
CMV ViremiaCMV Disease
Atara Biotherapeutics
Next Page